Global Psoriasis Industrial and Market studies with Focus on Plaque Psoriasis: Outlook to 2020
"Global
Psoriasis Market with Focus on Plaque Psoriasis: Outlook to 2020"
The Report covers current Market Trends, Worldwide Analysis, Global
Forecast, Review, Share, Size, Growth, Effect.
Description-
Psoriasis
is a chronic inflammatory skin disease primarily causing scaling and
inflammation of skin, characterized by sharply demarcated, scaly, red
skin lesions most often on the elbows, knees, scalps, hands and feet.
It occurs when the body’s immune system sends out faulty signals
that speed up the growth cycle of skin cells. Psoriasis has been
majorly classified into Plaque psoriasis, Guttate psoriasis, Inverse
psoriasis, Pustular psoriasis and Erytherodermic psoriasis. It is an
autoimmune disease and may be triggered by smoking, alcohol
consumption, cold or dry weather and stress.
In
the wake of lesser treatment options and costly therapies, psoriasis
remains as an under treated disease. Psoriasis treatment can be
divided into three main groups: topical treatment, light therapy, and
systemic medication based on the severity of the disease. The typical
treatment options include TNF inhibitors and IL inhibitors. However,
various therapies and drugs are in the pipeline and it is expected
that treatment options will improve over time with higher efficacy
and lower costs.
The global market for psoriasis has been
increasing consistently over the last few years. The major factors
contributing to the growth of the global psoriasis market are
increasing smoking and alcohol consumption trends globally. Surging
smoking population, increased spending on medicines, increasing sales
of prescription drugs and escalating health care expenditure are the
key growth drivers of the market. However, growth of the market is
hindered by extensive drug development and approval process and
side-effects associated with the existing medication for psoriasis.
Table
of Content
1. Market Overview
1.1 Psoriasis
1.2 Types
1.2.1 Plaque Psoriasis
1.2.2 Guttate Psoriasis
1.2.3 Inverse Psoriasis
1.2.4 Pustular Psoriasis
1.2.5 Erytherodermic Psoriasis
1.3 Causes
1.4 Symptoms by Types
1.4.1 Plaque Psoriasis
1.4.2 Guttate Psoriasis
1.4.3 Inverse Psoriasis
1.4.4 Pustular Psoriasis
1.4.5 Erytherodermic Psoriasis
1.5 Diagnosis
1.6 Treatment Options
1.6.1 Topical Treatments
1.6.2 Light Therapy or Phototherapy
1.6.3 Systemic Treatments
1.1 Psoriasis
1.2 Types
1.2.1 Plaque Psoriasis
1.2.2 Guttate Psoriasis
1.2.3 Inverse Psoriasis
1.2.4 Pustular Psoriasis
1.2.5 Erytherodermic Psoriasis
1.3 Causes
1.4 Symptoms by Types
1.4.1 Plaque Psoriasis
1.4.2 Guttate Psoriasis
1.4.3 Inverse Psoriasis
1.4.4 Pustular Psoriasis
1.4.5 Erytherodermic Psoriasis
1.5 Diagnosis
1.6 Treatment Options
1.6.1 Topical Treatments
1.6.2 Light Therapy or Phototherapy
1.6.3 Systemic Treatments
2. Global Market
2.1 Global Psoriasis Market by Value
2.2 Global Psoriasis Market by Therapy
2.1 Global Psoriasis Market by Value
2.2 Global Psoriasis Market by Therapy
3. The US Market
3.1 Autoimmune Disease Market
3.1.1 The US Autoimmune Disease Market by Value
3.2 Psoriasis Market
3.2.1 The US Psoriasis Prevalence
3.2.2 The US Psoriasis Market by Value
3.2.3 The US Psoriasis Market by Treatment
3.2.4 The US Psoriasis IL-Inhibitors Market by Value
3.3 Plaque Psoriasis Market
3.1 Autoimmune Disease Market
3.1.1 The US Autoimmune Disease Market by Value
3.2 Psoriasis Market
3.2.1 The US Psoriasis Prevalence
3.2.2 The US Psoriasis Market by Value
3.2.3 The US Psoriasis Market by Treatment
3.2.4 The US Psoriasis IL-Inhibitors Market by Value
3.3 Plaque Psoriasis Market
Comments
Post a Comment